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Background: This is the first study analyzing levels of physical activity in a sample of quarantined adults with
chronic conditions. The aim of this study was to compare moderate- and vigorous-intensity physical activity levels
in Spanish adults with chronic conditions before and during coronavirus disease 2019 (COVID-19) quarantine.
Methods: A cross-sectional online survey was administered during the COVID-19 quarantine in Spain. A total of
163 participants with chronic conditions (113 females and 47 males; age range 18–64 years) completed the survey.
A total of 26 chronic conditions were included. Participants self-reported average minutes/day of moderate and
vigorous physical activity before and during quarantine. Differences in moderate- and vigorous-intensity physical
activity levels before and during COVID-19 quarantine (overall, by gender, by age, by number of chronic con-
ditions and by each chronic condition) were assessed by Wilcoxon-signed rank test. Results: During COVID-19
quarantine, there was a significant decrease of moderate-intensity physical activity in Spanish people with chronic
conditions (in both males and females, in those aged 18–24, 25–34, 35–44 and 55–64 years, in those with multi-
morbidity, in those with one/two chronic condition/s, and in those diagnosed with asthma/hypercholesterolaemia/
chronic skin disease/haemorrhoids). Also, there was a significant decrease of vigorous-intensity physical activity in
Spanish males with chronic conditions and in those with multimorbidity. Conclusions: These results should be
considered to develop effective strategies of physical activity promotion targeting these specific groups when
new quarantine or restriction measures are implemented, in order to avoid new significant decreases of physical
activity in these vulnerable populations.
. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . .











oronavirus disease 2019 (COVID-19) was declared a global pan-
demic by World Health Organization on the 11 March of 2020.1
At the time of writing (20 July 2020), 14 043 176 cases have been
diagnosed globally, resulting in 597 583 fatalities thus far.2 Spain is
among the countries with the highest number of cases, with a total
of 260 255 cases diagnosed that have resulted in 28 420 fatalities thus
far.3 Due to the proven effectiveness of traditional public health
measures interrupting human-to-human transmission of viruses,4
on 15tMarch of 2020 the Spanish Government approved a period
of quarantine due to COVID-19, in order to fight the spread of the
virus.5,6
During the quarantine period, the Spanish population were
instructed to stay in their homes and, by consequence, interrupt
their usual activities.5,6 As prolonged home stays can increase behav-
iours that lead to inactivity, maintaining regular physical activity
and routinely exercising in a safe home environment is an important
strategy for healthy living during the coronavirus crisis.7
In this context, special attention should be paid to people with
chronic conditions because they are a vulnerable group in the
COVID-19 pandemic, as they have higher risk of severe disease
and mortality owing to COVID-19.8–10 Participating in regular
physical activity during COVID-19 quarantine is important for peo-
ple with chronic conditions because greater levels of physical activity
in this population are associated with both positive affect and phys-
ical functioning.11,12 Indeed, physical activity is a potential health
promotion modality for people with chronic conditions,13 as it may
ameliorate-associated depression, mobility difficulties and pain.14
Furthermore, as physical activity has shown to be an effective
therapy for most chronic diseases with direct effects on both mental
and physical health, physical activity has now been recommended as
therapy to address the mental and physical consequences of COVID-
19 quarantine.15,16 Therefore, it is very important that, during quar-
antine periods, people with chronic conditions maintain adequate
levels of physical activity by meeting the global recommendations on
physical activity for health: at least 150 min/week of moderate-
intensity physical activity, or 75 min/week of vigorous-intensity
physical activity, or an equivalent combination of moderate- and
vigorous-intensity physical activity.17,18
However, to the best of our knowledge no studies have been
published yet analyzing the levels of physical activity in adults
with chronic conditions before and during COVID-19 quarantine.
Given this background, this study aimed to compare moderate- and
vigorous-intensity physical activity levels in Spanish adults with
chronic conditions before and during COVID-19 quarantine (over-
all, by gender, by age, by number of chronic conditions and by each
chronic condition), in order to identify specific groups that may
require target physical activity interventions. It is hypothesized
that in those with any chronic condition moderate intensity physical
activity and vigorous intensity physical activity would had decreased
from before to during COVID-19 quarantine.
Methods
The survey
A cross-sectional online survey was administered during the
COVID-19 quarantine in Spain. The Spanish quarantine started
on the 15 March 2020.18 This study followed the principles of the
World Medical Association Declaration of Helsinki and was
approved by the Ethics Committee of Research in Humans of the
University of Valencia (1 April 2020; register code 1278789). The
study lasted one month (from 1 April 2020 to 1 May 2020). On 2
May 2020, the gradual opening in Spain commenced and physical
activity outdoors was allowed again, albeit with time restrictions.19
Spanish adults aged 18 years and over (age range of those who
completed the survey 18–64 years) that were quarantined due to
COVID-19 were eligible to participate. A convenience sample of
participants was recruited through social media (e.g. Facebook,
Twitter, Whatsapp). They were directed to a data encrypted website,
where they indicated their consent to participate after reading an
information sheet and they confirmed that they were in a quarantine
situation. The data provided were anonymous and treated accord-
ingly to Spanish law regarding general data protection. This manu-
script was written in accordance with the STROBE Statement
(Strengthening the Reporting of Observational studies in
Epidemiology).20
Chronic conditions
Participants were asked: ‘Have you ever been diagnosed by a health
professional with any of the following chronic conditions? (tick all
that apply)’. Chronic conditions included were: depression, anxiety,
other psychiatric disorders, obesity, hypertension, varicose veins of
lower extremities, osteoarthritis, chronic neck pain, chronic low
back pain, chronic allergy excluding allergic asthma, asthma includ-
ing allergic asthma, chronic bronchitis, diabetes type 2, cataracts,
peptic ulcer disease, urinary incontinence or urine control problems,
hypercholesterolaemia, chronic skin disease, chronic constipation,
chronic migraine and other frequent chronic headaches, haemor-
rhoids, cancer, osteoporosis, thyroid disease, renal disease and in-
jury. This list of chronic conditions was based on the list of chronic
diseases of the Spanish National Health Survey.21 Multimorbidity
was defined as the co-occurrence of two or more chronic conditions.
Physical activity
First, vigorous and moderate physical activity were described to
participants: ‘Vigorous physical activities refer to activities that
take hard physical effort and make you breathe much harder than
normal. Moderate activities refer to activities that take moderate
physical effort and make you breathe somewhat harder than nor-
mal’. Then, participants were asked: (i) How much time on an
average day did you usually spend in moderate activity before quar-
antine? (ii) How much time on an average day do you spend in
moderate activity during quarantine? (iii) How much time on an
average day did you usually spend in vigorous activity before quar-
antine? (iv) How much time on an average day do you spend in
vigorous activity during quarantine? Responses were reported in
minutes/day.
Statistical analysis
The statistical analysis was performed with SPSS 23.0 (IBM, NY,
USA). The Kołmogorov–Smirnov test was applied to check normal-
ity. Differences in moderate- and vigorous-intensity physical activity
levels before and during COVID-19 quarantine (overall, by gender, by
age, by number of chronic conditions and by each chronic condition)
were assessed by Wilcoxon-signed rank test, providing the mean and
standard deviation of each group, the mean difference, the Z and the
P values. In addition, the effect size was calculated using Rosenthal’s
formula (r¼Z/N),22 and it was classified as small (0.10), medium
(0.30) and large (0.50).23 There were missing data only on the follow-
ing variables: gender (n¼ 3: 1.84%) and age (n¼ 3: 1.84%).
Complete-case analysis was carried out (only participants for which
we had no missing data on the variables of interest were included in
the analyses, while participants with any missing data were excluded).
The level of statistical significance was set at P< 0.05.
Results
A total of 163 participants with chronic conditions completed the
survey. The gender distribution was males (n¼ 47) and females
(n¼ 113). The age distribution was: 18–24 years (n¼ 59), 25–
34 years (n¼ 52), 35–44 years (n¼ 28), 45–54 years (n¼ 11) and
55–64 years (n¼ 10). Distribution by number of chronic conditions
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was 1 chronic condition (n¼ 70), 2 chronic conditions (n¼ 46), 3
chronic conditions (n¼ 22), 4 chronic conditions (n¼ 13), 5 chron-
ic conditions (n¼ 6), 6 chronic conditions (n¼ 2), 7 chronic con-
ditions (n¼ 3) and 8 chronic conditions (n¼ 1). The number of
participants with each chronic condition was depression (n¼ 23),
anxiety (n¼ 13), other psychiatric disorders (n¼ 11), obesity
(n¼ 25), hypertension (n¼ 17), varicose veins of lower extremities
(n¼ 20), osteoarthritis (n¼ 4), chronic neck pain (n¼ 14), chronic
low back pain (n¼ 18), chronic allergy excluding allergic asthma
(n¼ 22), asthma including allergic asthma (n¼ 25), chronic bron-
chitis (n¼ 5), diabetes type 2 (n¼ 3), cataracts (n¼ 4), peptic ulcer
disease (n¼ 2), urinary incontinence or urine control problems
(n¼ 1), hypercholesterolaemia (n¼ 25), chronic skin disease
(n¼ 21), chronic constipation (n¼ 7), chronic migraine and other
frequent chronic headaches (n¼ 31), haemorrhoids (n¼ 21), cancer
(n¼ 2), osteoporosis (n¼ 6), thyroid disease (n¼ 12), renal disease
(n¼ 11) and injury (n¼ 8).
Moderate-intensity physical activity significantly decreased in
Spanish people with chronic conditions during COVID-19 quaran-
tine (mean difference: 30 min/day; P< 0.001). This decrease was
significant in both males (mean difference: 22.1 min/day;
P¼ 0.006) and females (mean difference: 33.2 min/day; P< 0.001).
Also, this decrease was significant in those aged 18–44 and 55–
64 years [P< 0.05; table 1(a)]. Vigorous-intensity physical activity
significantly decreased in Spanish males with chronic conditions
during COVID-19 quarantine [mean difference: 15.5 min/day;
P¼ 0.025; table 1(b)].
According to number of chronic conditions, moderate-intensity
physical activity significantly decreased during COVID-19
quarantine in those with multimorbidity (mean difference:
Table 1 Comparison of physical activity in minutes/day before and during COVID-19 quarantine (overall, by gender and by age)
n Before During Difference Z P-valuea rb
(a) Moderate intensity
Overall 163 90.5 (87.1) 60.5 (51.3) 30.0 4.692 <0.001*** 0.259
Gender Male 47 79.7 (61.0) 57.6 (44.9) 22.1 2.764 0.006** 0.285
Female 113 95.6 (95.9) 62.4 (54.0) 33.2 3.858 <0.001*** 0.256
Age (years) 18–24 59 79.9 (64.3) 56.3 (42.6) 23.6 2.885 0.004** 0.265
25–34 52 100.2 (90.6) 77.0 (59.8) 23.2 2.084 0.037* 0.204
35–44 28 95.5 (113.8) 52.5 (52.2) 43.0 2.044 0.041* 0.273
45–54 11 99.1 (133.8) 37.3 (40.8) 61.8 1.854 0.064 0.395
55–64 10 90.5 (44.0) 43.4 (46.0) 47.1 1.961 0.049* 0.438
(b) Vigorous intensity
Overall 163 40.6 (47.6) 34.6 (39.2) 6.0 1.449 0.147 0.080
Gender Male 47 55.7 (52.8) 40.2 (37.5) 15.5 2.241 0.025* 0.231
Female 113 35.3 (44.3) 32.7 (40.0) 2.6 0.482 0.630 0.032
Age (years) 18–24 59 49.8 (51.4) 39.9 (38.0) 9.9 1.217 0.223 0.112
25–34 52 42.3 (51.4) 36.5 (44.5) 5.8 0.857 0.391 0.084
35–44 28 32.7 (38.7) 31.8 (37.6) 0.9 0.188 0.851 0.025
45–54 11 24.6 (35.0) 21.8 (30.3) 2.8 0.272 0.785 0.058
55–64 10 29.0 (32.8) 18.0 (30.5) 11.0 1.603 0.109 0.358
Notes: Values are average (SD).
a: P-values were based on Wilcoxon-signed rank test. *P<0.05, **P<0.01 and ***P<0.001.
b: r ¼ Z/N; N¼n*2; Small 0.10, Medium 0.30 and bold values signifies Large effect sizes ( 0.5).
Table 2 Comparison of physical activity in minutes/day before and during COVID-19 quarantine (by number of chronic conditions)
n Before During Diffference Z P-value a rb
(a) Moderate intensity
Multimorbidityc 93 97.4 (95.6) 67.3 (52.8) 30.1 3.429 <0.001*** 0.251
1 chronic condition 70 81.4 (74.0) 51.5 (48.2) 29.9 3.263 0.001** 0.275
2 chronic conditions 46 98.5 (86.5) 63.7 (56.0) 34.8 3.088 0.002** 0.322
3 chronic conditions 22 76.4 (77.9) 60.7 (56.8) 15.7 0.966 0.334 0.145
4 chronic conditions 13 117.8 (120.8) 83.1 (35.0) 34.7 1.080 0.280 0.211
5 chronic conditions 6 135.0 (172.6) 71.7 (47.5) 63.3 0.730 0.465 0.210
6 chronic conditions 2 105.0 (106.1) 135.0 (63.6) þ30.0 1.000 0.317 20.500
7 chronic conditions 3 100.0 (62.5) 60.0 (30.0) 40.0 1.069 0.285 0.436
8 chronic conditions 1 0.0 () 30.0 () þ30.0 – – –
(b) Vigorous intensity
Multimorbidityc 93 44.6 (53.7) 33.2 (35.1) 11.4 2.000 0.045* 0.146
1 chronic condition 70 35.2 (37.7) 36.4 (44.4) þ1.2 0.073 0.942 0.006
2 chronic conditions 46 43.6 (57.9) 28.7 (32.2) 14.9 1.918 0.055 0.200
3 chronic conditions 22 45.5 (55.0) 33.4 (33.3) 12.1 1.182 0.237 0.178
4 chronic conditions 13 52.3 (44.9) 51.9 (43.6) 0.4 0.344 0.731 0.067
5 chronic conditions 6 35.0 (55.0) 37.5 (48.1) þ2.5 0.447 0.655 0.129
6 chronic conditions 2 30.0 (42.4) 15.0 (21.2) 15.0 1.000 0.317 20.500
7 chronic conditions 3 65.0 (48.2) 35.0 (22.9) 30.0 0.534 0.593 0.218
8 chronic conditions 1 0.0 () 0.0 () 0.0 – – –
Notes: Values are average (SD).
a: P-values were based on Wilcoxon-signed rank test. *P<0.05, **P<0.01 and ***P<0.001.
b: r ¼ Z/N; N¼n*2; Small 0.10, Medium 0.30 and bold values signifies Large effect sizes ( 0.5).
c: Multimorbidity is defined as the co-occurrence of two or more chronic conditions.
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Table 3 Comparison of moderate-intensity physical activity in minutes/day before and during COVID-19 quarantine (by each chronic
condition)
Chronic condition n Before During Difference Z P-value a rb
Depression 23 95.7 (112.6) 74.6 (64.9) 21.1 0.904 0.366 0.133
Anxiety 13 150.0 (163.9) 65.8 (41.3) 84.2 1.637 0.102 0.321
Other psychiatric disorders 11 90.5 (133.4) 64.1 (39.2) 26.4 0.119 0.905 0.025
Obesity 25 69.6 (60.7) 54.0 (40.6) 15.6 1.423 0.155 0.201
Hypertension 17 98.8 (107.0) 74.7 (55.6) 24.1 0.942 0.346 0.161
Varicose veins of lower extremities 20 93.0 (99.2) 73.3 (54.5) 19.7 0.885 0.376 0.140
Osteoarthritis 4 135.0 (79.4) 77.5 (69.5) 57.5 1.069 0.285 0.378
Chronic neck pain 14 109.3 (126.0) 77.5 (57.5) 31.8 0.894 0.371 0.169
Chronic low back pain 18 106.1 (70.9) 87.7 (63.2) 18.4 1.221 0.222 0.203
Chronic allergy (excluding allergic asthma) 22 83.2 (61.4) 62.7 (46.7) 20.5 1.550 0.121 0.233
Asthma (including allergic asthma) 25 84.8 (50.5) 58.6 (40.6) 26.2 2.225 0.026* 0.314
Chronic bronchitis 5 174.0 (183.0) 72.0 (54.5) 102 1.603 0.109 20.507
Diabetes type 2 3 60.0 (20.0) 33.3 (41.6) 26.7 1.341 0.180 20.547
Cataracts 4 172.5 (205.5) 75.0 (30.0) 97.5 1.341 0.180 0.474
Peptic ulcer disease 2 30.0 (42.4) 45.0 (21.2) þ15 1.000 0.317 0.500
Urinary incontinence or urine control problems 1 120.0 () 120.0 () 0.0 – – –
Hypercholesterolaemia 25 109.2 (105.0) 70.2 (58.5) 39.0 2.538 0.011* 0.359
Chronic skin disease 21 98.6 (107.3) 54.3 (53.7) 44.3 2.892 0.004** 0.446
Chronic constipation 7 111.4 (51.1) 55.7 (47.2) 55.7 1.913 0.056 20.511
Chronic migraine and other frequent chronic headaches 31 77.9 (96.3) 58.1 (41.8) 19.8 1.033 0.301 0.131
Haemorrhoids 21 98.9 (90.8) 48.8 (46.7) 50.1 2.597 0.009** 0.400
Cancer 2 90.0 (42.4) 60.0 (84.9) 30.0 1.000 0.317 20.500
Osteoporosis 6 105.0 (59.2) 80.0 (62.0) 25.0 1.632 0.102 0.471
Thyroid disease 12 72.5 (50.3) 70.8 (37.5) 1.7 0.060 0.952 0.012
Renal disease 11 85.4 (45.0) 73.6 (76.1) 11.8 1.121 0.262 0.239
Injury 8 45.1 (64.0) 67.5 (26.6) þ22.4 1.207 0.227 0.301
Notes: Values are average (SD).
a: P-values were based on Wilcoxon-signed rank test. *P<0.05, **P<0.01 and ***P<0.001.
b: r ¼ Z/N; N¼n*2; Small 0.10, Medium 0.30 and bold values signifies Large effect sizes ( 0.5).
Table 4 Comparison of vigorous-intensity physical activity in minutes/day before and during COVID-19 quarantine (by each chronic
condition)
Chronic condition n Before During Difference Z P-valuea rb
Depression 23 35.0 (37.3) 32.6 (37.9) 2.4 0.411 0.681 0.060
Anxiety 13 50.8 (33.3) 45.8 (32.5) 5.0 0.602 0.547 0.118
Other psychiatric disorders 11 17.3 (30.1) 23.6 (24.1) þ6.3 1.021 0.307 0.217
Obesity 25 41.6 (58.2) 33.4 (33.2) 8.2 0.550 0.582 0.077
Hypertension 17 35.0 (37.7) 30.6 (37.8) 4.4 1.131 0.258 0.194
Varicose veins of lower extremities 20 31.5 (56.3) 15.3 (22.1) 16.2 1.642 0.100 0.259
Osteoarthritis 4 67.5 (51.2) 37.5 (37.7) 30 1.341 0.180 0.474
Chronic neck pain 14 41.8 (46.4) 40.4 (36.8) 1.4 0.118 0.905 0.022
Chronic low back pain 18 61.1 (48.5) 51.4 (40.8) 9.7 1.025 0.305 0.170
Chronic allergy (excluding allergic asthma) 22 42.7 (45.9) 30.9 (33.1) 11.8 1.055 0.291 0.159
Asthma (including allergic asthma) 25 41.4 (42.3) 35.6 (38.1) 5.8 0.565 0.571 0.080
Chronic bronchitis 5 60.0 (60.0) 50.0 (53.9) 10.0 0.447 0.655 0.141
Diabetes type 2 3 40.0 (45.8) 36.7 (32.1) 3.3 0.447 0.655 0.182
Cataracts 4 15.0 (30.0) 20.0 (28.3) þ5.0 1.000 0.317 0.353
Peptic ulcer disease 2 120.0 (169.7) 30.0 (42.4) 90.0 1.000 0.317 20.500
Urinary incontinence or urine control problems 1 120.0 () 120.0 () 0.0 – – –
Hypercholesterolaemia 25 46.8 (49.2) 48.6 (54.8) þ1.8 0.095 0.924 0.013
Chronic skin disease 21 32.9 (39.2) 27.9 (36.2) 5.0 0.438 0.661 0.067
Chronic constipation 7 52.1 (41.6) 24.4 (26.4) 27.7 1.165 0.244 0.311
Chronic migraine and other frequent chronic headaches 31 36.3 (42.0) 36.5 (39.5) þ0.2 0.444 0.656 0.056
Haemorrhoids 21 55.7 (63.1) 28.3 (31.3) 27.4 1.829 0.067 0.282
Cancer 2 60.0 (84.9) 30.0 (42.4) 30.0 0.447 0.655 0.223
Osteoporosis 6 80.0 (90.3) 35.0 (48.1) 45.0 1.603 0.109 0.462
Thyroid disease 12 26.7 (51.9) 40.4 (43.3) þ13.7 1.122 0.261 0.229
Renal disease 11 46.4 (44.8) 20.9 (23.3) 25.5 1.572 0.116 0.335
Injury 8 41.3 (53.0) 45.0 (40.1) þ3.7 0.365 0.715 0.091
Notes: Values are average (SD).
a: P-values were based on Wilcoxon-signed rank test. *P<0.05, **P<0.01 and ***P<0.001.
b: r ¼ Z/N; N¼n*2; Small 0.10, Medium 0.30 and bold values signifies Large effect sizes ( 0.5)
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30.1 min/day; P< 0.001), in those with one chronic condition
(mean difference: 29.9 min/day; P¼ 0.001) and in those with two
chronic conditions [mean difference: 34.8 min/day; P¼ 0.002;
table 2(a)]. Vigorous-intensity physical activity significantly
decreased during COVID-19 quarantine in those with multimorbid-
ity [mean difference: 11.4 min/day; P¼ 0.045; table 2(b)].
Regarding each chronic condition, moderate-intensity physical
activity significantly decreased during COVID-19 quarantine in
those diagnosed with asthma (mean difference: 26.2 min/day;
P¼ 0.026), hypercholesterolaemia (mean difference: 39.0 min/day;
P¼ 0.011), chronic skin disease (mean difference: 44.3 min/day;
P¼ 0.004) and haemorrhoids (mean difference: 50.1 min/day;
P¼ 0.009; table 3). There were no significant differences in
vigorous-intensity physical activity by each chronic condition before
and during COVID-19 quarantine (table 4).
Discussion
To our knowledge, this is the first study analyzing levels of physical
activity in a sample of quarantined adults with chronic conditions.
The results of this study showed significant decreases of both mod-
erate and vigorous physical activity during COVID-19 quarantine in
Spanish people with chronic conditions. These results differ from a
recent study that analyzed physical activity levels during quarantine
in Spanish adult general population (n¼ 2741), which found an
increase of physical activity.24
There are several plausible reasons to explain the physical activity
reductions in Spanish people with chronic conditions that were
observed in the present study and the difference with the results
obtained in the general adult population.24 First, people with chron-
ic conditions are a vulnerable group and they experience a greater
number of barriers to physical activity participation than the general
adult population,25–28 and it is likely that it is more difficult to
overcome these barriers during a quarantine situation. Second,
quarantine due to COVID-19 could produce, in those with chronic
conditions, feelings of loneliness, lack of social support and isola-
tion, which are also associated with reductions of physical activity
and chronic conditions.29–33 Third, natural light and natural envir-
onment exposure deprivation during quarantine might lead to a
negative mood state, which consequently, may predispose for less
physical activity.34 Fourth, the prohibition of doing physical activity
outdoors (very frequent in Spain due to the good weather of the
country), could highly contribute to this reduction in physical ac-
tivity levels in people with chronic conditions, as Spanish people are
more used to outdoor than indoor physical activity.
Also, the negative consequences that this significant reduction in
physical activity can cause in people with chronic conditions should
be considered in order to prevent other health problems. For ex-
ample, several studies have reported that short-term physical in-
activity (i.e.14 days) causes reversible metabolic derangements and
changes in body composition.35 Moreover, other negative short-
term effects of physical inactivity are impaired endothelial function,
arterial stiffness, increased arterial tone, insulin resistance, increased
blood pressure and dyslipidemia.36,37 Therefore, it is urgent and
necessary to develop effective strategies of physical activity promo-
tion in people with chronic conditions in order to avoid potential
subsequent complications in their conditions.
The main strength of this study is that it is the first study report-
ing levels of physical activity in a sample of quarantined adults with
chronic conditions. Another strength of the present study is the high
number of chronic conditions included (a total of 26 chronic con-
ditions). However, the present findings must be interpreted in light
of the study limitations. First, physical activity and chronic condi-
tions were self-reported, potentially introducing self-reporting bias
into the findings. Second, analyses were cross-sectional and thus it
was not possible to determine trajectories of physical activity during
the whole period of quarantine. Third, due to the method of
sampling (convenience sampling), there is the possibility of a selec-
tion bias.
Conclusions
During COVID-19 quarantine, there was a significant decrease of
moderate-intensity physical activity in Spanish people with chronic
conditions (in both males and females, in those aged 18–44 and 55–
64 years, in those with multimorbidity, in those with one/two chron-
ic condition/s, and in those diagnosed with asthma/hypercholester-
olaemia/chronic skin disease/haemorrhoids). Also, there was a
significant decrease of vigorous-intensity physical activity in
Spanish males with chronic conditions and in those with multimor-
bidity. These results should be considered to develop effective strat-
egies of physical activity promotion targeting these specific groups
when new quarantine or restriction measures are implemented, in
order to avoid new significant decreases of physical activity in these
vulnerable populations. Owing to the restrictions imposed during
quarantine the promotion of appropriate home-based exercises are
required for those with chronic conditions, it may be best to pro-
mote exercise programmes during quarantine online either utilizing
existing or developing new, exercise programmes. Moreover, simple
brief exercise advice could also be provided.
Conflicts of interest: None declared.
Data availability
The data that support the findings of this study are available from
the corresponding author [G.F.L.S.], upon reasonable request.
Key points
• First study analyzing levels of physical activity in quarantined
adults with chronic conditions.
• Significant decrease of physical activity in Spanish adults with
chronic conditions.
• These results should be considered to develop strategies of
physical activity promotion.
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